Goldman Sachs’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Sell |
14,000
-12,200
| -47% | -$2.57M | ﹤0.01% | 4283 |
|
|
2025
Q4 | $5.21M | Sell |
26,200
-13,900
| -35% | -$2.81M | ﹤0.01% | 3704 |
|
|
2025
Q3 | $8.14M | Hold |
40,100
| – | – | ﹤0.01% | 3171 |
|
|
2025
Q2 | $7.06M | Sell |
40,100
-25,000
| -38% | -$3.76M | ﹤0.01% | 3088 |
|
|
2025
Q1 | $8.76M | Hold |
65,100
| – | – | ﹤0.01% | 2819 |
|
|
2024
Q4 | $8.22M | Sell |
65,100
-20,000
| -24% | -$2.97M | ﹤0.01% | 2981 |
|
|
2024
Q3 | $14.1M | Buy |
85,100
+45,100
| +113% | +$6.82M | ﹤0.01% | 2374 |
|
|
2024
Q2 | $5.32M | Buy |
+40,000
| New | +$4.82M | ﹤0.01% | 3092 |
|
|
2018
Q4 | – | Sell |
-1,300
| Closed | -$37K | – | 5660 |
|
|
2018
Q3 | $37K | Sell |
1,300
-27,600
| -96% | -$911K | ﹤0.01% | 5339 |
|
|
2018
Q2 | $970K | Buy |
28,900
+24,500
| +557% | +$762K | ﹤0.01% | 4097 |
|
|
2018
Q1 | $107K | Sell |
4,400
-40,600
| -90% | -$808K | ﹤0.01% | 5261 |
|
|
2017
Q4 | $682K | Sell |
45,000
-95,300
| -68% | -$1.34M | ﹤0.01% | 4582 |
|
|
2017
Q3 | $2.31M | Buy |
140,300
+96,100
| +217% | +$1.63M | ﹤0.01% | 3856 |
|
|
2017
Q2 | $855K | Sell |
44,200
-12,800
| -22% | -$223K | ﹤0.01% | 4607 |
|
|
2017
Q1 | $1.01M | Buy |
57,000
+12,400
| +28% | +$230K | ﹤0.01% | 4368 |
|
|
2016
Q4 | $662K | Sell |
44,600
-148,700
| -77% | -$2.67M | ﹤0.01% | 4816 |
|
|
2016
Q3 | $4.38M | Buy |
193,300
+167,100
| +638% | +$4.35M | ﹤0.01% | 3152 |
|
|
2016
Q2 | $724K | Sell |
26,200
-93,800
| -78% | -$2.77M | ﹤0.01% | 4502 |
|
|
2016
Q1 | $3.47M | Buy |
120,000
+4,100
| +4% | +$107K | ﹤0.01% | 3009 |
|
|
2015
Q4 | $3.51M | Buy |
115,900
+81,700
| +239% | +$2.68M | ﹤0.01% | 3149 |
|
|
2015
Q3 | $1.26M | Sell |
34,200
-477,400
| -93% | -$24.7M | ﹤0.01% | 4241 |
|
|
2015
Q2 | $29.6M | Buy |
511,600
+332,600
| +186% | +$17M | 0.01% | 1508 |
|
|
2015
Q1 | $8.86M | Sell |
179,000
-1,800
| -1% | -$84.1K | ﹤0.01% | 2390 |
|
|
2014
Q4 | $9.16M | Buy |
180,800
+122,800
| +212% | +$6.42M | ﹤0.01% | 2422 |
|
|
2014
Q3 | $3.44M | Sell |
58,000
-197,800
| -77% | -$11M | ﹤0.01% | 3386 |
|
|
2014
Q2 | $12M | Buy |
255,800
+70,700
| +38% | +$3.19M | ﹤0.01% | 2223 |
|
|
2014
Q1 | $7.92M | Buy |
185,100
+12,800
| +7% | +$565K | ﹤0.01% | 2567 |
|
|
2013
Q4 | $7.26M | Buy |
172,300
+117,600
| +215% | +$5.12M | ﹤0.01% | 2671 |
|
|
2013
Q3 | $2.25M | Buy |
54,700
+31,000
| +131% | +$1.3M | ﹤0.01% | 3806 |
|
|
2013
Q2 | $1.09M | Buy |
+23,700
| New | +$1.06M | ﹤0.01% | 4322 |
|
Other funds holding THC
VPM
VCM
LPC
Goldman Sachs's THC Position: Q1 2026 in Review
Goldman Sachs increased its Tenet Healthcare (THC) stake by 21% in Q1 2026, buying an estimated $14.6M and bringing the position to 404,257 shares worth $76.3M. The position accounts for 0.01% of the portfolio, ranked #1236.
Goldman Sachs first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q4 2013. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Goldman Sachs held 404,257 shares of Tenet Healthcare worth $76.3M as of Q1 2026.
- Goldman Sachs bought 69,271 Tenet Healthcare shares in Q1 2026, an estimated $14.6M.
- Tenet Healthcare made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1236 holding.
- Goldman Sachs first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Tenet Healthcare position peaked at $211M in Q4 2013.
- 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.